Nanobiotix S.A. (EPA:NANO)
France flag France · Delayed Price · Currency is EUR
17.46
-0.50 (-2.78%)
At close: Jan 30, 2026

Nanobiotix Revenue

Nanobiotix had revenue of 13.32M EUR in the half year ending June 30, 2025, with 186.77% growth. This brings the company's revenue in the last twelve months to 10.16M, down -75.93% year-over-year. In the year 2024, Nanobiotix had annual revenue of -7.19M.

Revenue (ttm)
10.16M
Revenue Growth
-75.93%
P/S Ratio
83.16
Revenue / Employee
98.63K
Employees
103
Market Cap
844.85M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024-7.19M-43.40M-
Dec 31, 202336.21M31.43M658.10%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M135.00K5.37%
Dec 31, 20202.51M-29.00K-1.14%
Dec 31, 20192.54M-938.00K-26.96%
Dec 31, 20183.48M-243.00K-6.53%
Dec 31, 20173.72M-1.70M-31.35%
Dec 31, 20165.42M1.41M35.03%
Dec 31, 20154.02M1.24M44.91%
Dec 31, 20142.77M1.18M73.67%
Dec 31, 20131.60M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE179.91M
Cellectis70.36M
Genfit45.13M
MedinCell32.44M
Inventiva16.97M
Adocia12.88M
Innate Pharma12.64M
Transgene7.58M
Revenue Rankings